Work

Anticoagulant effects of hirulog, ∗∗Hirulog™ brand direct thrombin inhibitor. a novel thrombin inhibitor, in patients with coronary artery disease

Year: 1993

Type: article

Study design: Clinical Trial

Source: The American Journal of Cardiology

DOI: 10.1016/0002-9149(93)90823-u

Authors: Christopher P. Cannon, John M. Maraganore, Joseph Loscalzo, Arthur McAllister, Karen Eddings, Dorinda George, Andrew P. Selwyn, Burt Adelman, Irving Fox, Eugene Braunwald, Peter Ganz

Institutions: Brigham and Women's Hospital, Biogen (United States), Harvard University

Language: English

Topic: Blood Coagulation and Thrombosis Mechanisms

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Heart, Lung, and Blood Institute

Awards: PLATELETS, PLATELET THROMBI, AND PLASMINOGEN ACTIVATION, G2853615930, ENDOTHELIAL DYSFUNCTION IN CORONARY ATHEROSCLEROSIS, Training Grant in Cardiovascular Research

OpenAlex ID: W2000464298

FWCI: 7.138

Cites: 29

Cited by: 82

Related to: 10